Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts

Qian Zhang, Larry D. Mesner, Gina M. Calabrese, Naomi Dirckx, Zhu Li, Angela Verardo, Qian Yang, Robert J. Tower, Marie Claude Faugere, Charles R. Farber, Thomas L. Clemens

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass.

Original languageEnglish
Article numbere142580
JournalJournal of Clinical Investigation
Issue number7
StatePublished - Apr 1 2021

Bibliographical note

Publisher Copyright:
Copyright: © 2021, American Society for Clinical Investigation.

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts'. Together they form a unique fingerprint.

Cite this